A nucleic acid aptamer for detecting human uveal melanoma cells

A technology for melanoma cells and nucleic acid aptamers, which can be used in measurement devices, DNA/RNA fragments, instruments, etc., can solve problems such as poor prognosis, and achieve the effects of low preparation cost, small molecular weight, and easy labeling

Pending Publication Date: 2018-05-15
HUNAN UNIV +1
View PDF0 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although there have been new advances in the diagnosis and treatment of uveal melanoma in the past few decades, its prognosis is still poor. About 31% of patients die of uveal melanoma within 5 years after diagnosis, and half of them will die after 25 years. of patients died

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A nucleic acid aptamer for detecting human uveal melanoma cells
  • A nucleic acid aptamer for detecting human uveal melanoma cells
  • A nucleic acid aptamer for detecting human uveal melanoma cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] Example 1: Screening of specific nucleic acid aptamers for human uveal melanoma cells (OCM-1)

[0022] (1) Design of the nucleic acid library and primers used:

[0023] Random nucleic acid library:

[0024] 5'-ATCCAGAGTGACGCAGCA(N25)TGGACACGGTGGCTTAGT-3'

[0025] Upstream primer: 5'-FITC-ATCCAGAGTGACGCAGCA--3';

[0026] Downstream primer: 5'-biotin-TGGACACGGTGGCTTAGT-3'.

[0027] (2) Positive screening:

[0028] 2.1 Incubation: Dissolve the above random nucleic acid library with binding buffer (D-PBS, 5 mM magnesium chloride), denature at 95°C for 5 minutes, quickly put it on ice, and let it stand for 10 minutes; then mix with the cultured and pretreated Human uveal melanoma cells (OCM-1) were incubated at 4°C for 1 hour.

[0029] 2.2 Dissociation: After the incubation, remove the solution in the incubation dish, wash the cells in the incubation dish with washing buffer (PBS, containing 0.45% glucose, 5 mM magnesium chloride); scrape the incubation dish with 1mL st...

Embodiment 2

[0037] Example 2: Identification of the sequence with the strongest specific binding ability to the OCM-1 cell line

[0038]First, digest the adherent OCM-1 cells from the culture dish with 0.2% EDTA, collect the cells into centrifuge tubes, and wash them by centrifugation with washing buffer (PBS, containing 0.45% glucose, 5 mM magnesium chloride) Several times; secondly, the final concentration of 200nM of the 5 sequences and the random library were added to the binding buffer (D-PBS, containing 0.45% glucose, 5mM magnesium chloride, 100mg / L tRNA, 1g / L BSA) soaked OCM -1 cells; then placed on a shaker at 4°C and incubated for 30min; after the incubation was completed, centrifuge and wash once with washing buffer (PBS, containing 0.45% glucose, 5 mM magnesium chloride), and perform fluorescence detection by flow cytometry (results See figure 2 ). The test results showed that ZH-12 had the strongest binding ability to OCM-1 cells.

Embodiment 3

[0039] Example 3: Target type identification and its affinity determination for OCM-1 cells

[0040] First, take 3 OCM-1 cell dishes that have been plated for 24 hours, and digest the cells from the culture dish with 0.2% EDTA, trypsin, and proteinase K respectively (0.2% EDTA was digested for 1 minute, trypsin and proteinase K Digested for 5 minutes), and then collected by centrifuge tubes (2 tubes for EDTA digested cells, one tube for trypsin and proteinase K digested cells), and then washed with washing buffer (PBS, containing 0.45% glucose, 5 mM magnesium chloride), then add 200nM ZH-12 to the cells, add 200nM random library to another tube of EDTA-digested cells, place in a shaker at 4°C and incubate for 30min, and then centrifuge and wash with washing buffer after incubation. Once, and finally use the flow cytometer to detect the fluorescent signal (the results are as follows: image 3 A). The results of flow cytometry showed that the binding amount of ZH-12 to OCM-1 d...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A nucleic acid aptamer used for detecting human uveal melanoma cells (OCM-1) and applications thereof in preparation of detection preparations are disclosed. Compared with the prior art, the nucleic acid aptamer and the applications are advantageous in that the prepared nucleic acid aptamer can specifically recognize the uveal melanoma cells, has good affinity, no immunogenicity, and a small molecular weight, and can be chemically synthesized in vitro; and different positions of the nucleic acid aptamer can be modified and substituted. In addition, the nucleic acid aptamer has advantages of astable sequence, capability of being convenient to store and mark, and the like. When the nucleic acid aptamer is adopted for detecting the human uveal melanoma cells, operation is simpler and rapider. The nucleic acid aptamer has a synthesis cost lower than antibody preparing costs, a short period and good reproducibility.

Description

technical field [0001] The invention relates to a nucleic acid aptamer and its application, in particular to a nucleic acid aptamer which can be used for detection of human uveal melanoma cells and clinical sample tissues and an application method for preparing a detection reagent. Background technique [0002] Uveal melanoma (Uveal melanoma) is the most common intraocular malignant tumor in adults. Its incidence rate accounts for the first place among intraocular tumors in foreign countries, and it is second only to retinoblastoma in China. the second place. Although there have been new advances in the diagnosis and treatment of uveal melanoma in the past few decades, its prognosis is still poor. About 31% of patients die of uveal melanoma within 5 years after diagnosis, and half of them will die after 25 years. of patients died. Metastasis is common in patients, and the liver is the most likely site of metastasis. The cumulative metastasis rate of uveal melanoma patient...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N15/115G01N33/574
CPCG01N33/57407C12N15/115Y02A50/30
Inventor 叶茂谭蔚泓张慧熊炜
Owner HUNAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap